Strong CAG Sales to Aid IDEXX Laboratories' (IDXX) Q2 Earnings
Here's How Much $100 Invested In IDEXX Laboratories 20 Years Ago Would Be Worth Today
Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $589
Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $589
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $589 From $596, Maintains Overweight Rating
Shareholders Are Optimistic That IDEXX Laboratories (NASDAQ:IDXX) Will Multiply In Value
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $510
P/E Ratio Insights for IDEXX Laboratories
TMO or IDXX: Which Is the Better Value Stock Right Now?
Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?
Looking Into IDEXX Laboratories's Recent Short Interest
Should You Invest in IDEXX Laboratories (IDXX)?
$100 Invested In This Stock 10 Years Ago Would Be Worth $700 Today
Jiangsu Leili Motor (300660.SZ): Downstream customers include multiple global medical instrument leading enterprises, such as Shenzhen Mindray Bio-Medical Electronics, IDEXX Laboratories Inc, Siemens, etc.
Jiangsu Leili Motor (300660.SZ) stated on its investor interaction platform on July 3 that the company has accumulated various types of products under categories such as linear actuators and voice coil motors in the medical field. Downstream customers include multiple global medical equipment industry leaders, such as Shenzhen Mindray Bio-medical Electronics, Idexx Laboratories Inc, and Siemens. The company has established a strategic partnership with Shenzhen Mindray Bio-medical Electronics to jointly promote the localization of core components of medical instruments. The company has advantages in excellent product performance, complete series, high global market recognition, outstanding product customization and technical research and development capabilities in the field.
IDEXX Laboratories to Release 2024 Second Quarter Financial Results
IDEXX Labs Is Maintained at Hold by Stifel
IDEXX Laboratories Analyst Ratings
Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $510
Express News | IDEXX Laboratories Inc : Stifel Cuts Target Price to $510 From $520